Table 3.

Immunoexpression of the different markers in MBC, myofibroblastomas phyllodes tumor, and PASH

Antibody	MBC (%)	Myofibroblastoma (%)	Phyllodes Tumor (%)	PASH (%)
SNAIL	34/34 (100%)	4/4 (100%)	14/14 (100%)	7/8 (87.5%)
EGFR	34/34 (100%)	0/4 (0%)	13/14 (92.9%)	8/8 (100%)
OSCAR	29/34 (85.3%)	0/4 (0%)	2/14 (14.3%)	0/8 (0%)
WS-KER	26/34 (76.5%)	0/4 (0%)	0/14 (0%)	0/8 (0%)
P63	23/34 (56.7%)	0/4 (0%)	0/14 (0%)	0/8 (0%)

MBC = metaplastic breast carcinoma

PASH = pseudoangiomatous stromal hyperplasia